Literature DB >> 2069157

Amegakaryocytic thrombocytopenia of 4 years duration: successful treatment with antithymocyte globulin.

M S Trimble1, M F Glynn, M C Brain.   

Abstract

Acquired amegakaryocytic thrombocytopenic purpura (AATP) is a rare cause of thrombocytopenia. Since it is a syndrome of diverse etiologies, the optimal treatment is often uncertain. In a patient with longstanding AATP, a complete remission was obtained with antithymocyte globulin.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2069157     DOI： 10.1002/ajh.2830370212

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  6 in total

Review 1.  Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes.

Authors:  Neal S Young
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

2.  Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up.

Authors:  Mehrzad Mirzania; Sedigheh Khalili; Akbar Hasanpoor; Ahmad Reza Shamshiri
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014

3.  Successful treatment of acquired amegakaryocytic thrombocytopenic purpura refractory to corticosteroids and intravenous immunoglobulin with antithymocyte globulin and cyclosporin.

Authors:  Pimjai Niparuck; Vichai Atichartakarn; Suporn Chuncharunee
Journal:  Int J Hematol       Date:  2008-07-15       Impact factor: 2.490

4.  Good response to cyclosporin in a child with acquired thrombocytopenic purpura.

Authors:  Shuchita Jain; Seema Kapoor; Ankur Singh; R N Mandal Ravi; Silky Jain
Journal:  Indian J Pediatr       Date:  2011-12-15       Impact factor: 5.319

5.  Danazol: an effective option in acquired amegakaryocytic thrombocytopaenic purpura.

Authors:  E Mulroy; S Gleeson; S Chiruka
Journal:  Case Rep Hematol       Date:  2015-04-05

6.  [Acquired amegacaryocytic thrombocytopenic purpura hiding acute myeloid leukemia].

Authors:  Hicham Eddou; Ali Zinebi; Abdelaziz Khalloufi; Mohammed Sina; Mehdi Mahtat; Kamal Doghmi; Mohammed Mikdame; Mohammed Karim Moudden; Mohammed El Baaj
Journal:  Pan Afr Med J       Date:  2017-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.